Randomized, Open-Label, Phase III Study Comparing Irinotecan With Paclitaxel in Patients With Advanced Gastric Cancer Without Severe Peritoneal Metastasis After Failure of Prior Combination Chemotherapy Using Fluoropyrimidine Plus Platinum: WJOG 4007 Trial

✍ Scribed by Hironaka, Shuichi (author);Ueda, Shinya (author);Yasui, Hirofumi (author);Nishina, Tomohiro (author);Tsuda, Masahiro (author);Tsumura, Takehiko (author);Sugimoto, Naotoshi (author);Shimodaira, Hideki (author);Tokunaga, Shinya (author);Moriwaki, Toshikazu (author);Esaki, Taito (author);Nagase, Michitaka (author);Fujitani, Kazumasa (author);Yamaguchi, Kensei (author);Ura, Takashi (author);Hamamoto, Yasuo (author);Morita, Satoshi (author);Okamoto, Isamu (author);Boku, Narikazu (author);Hyodo, Ichinosuke (author)

• Book ID: 121354475
• Publisher: American Society of Clinical Oncology
• Year: 2013
• Tongue: English
• Weight: 156 KB
• Volume: 31
• Category: Article
• ISSN: 0732-183X
• DOI: 10.1200/JCO.2012.48.5805